Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease.

To compare the efficacy and safety of adjunct lisuride therapy versus bromocriptine in patients with Parkinson's disease, already established on levodopa and suffering the long-term complications of therapy.